TP53 and ovarian carcinoma: Notably, immunohistochemical analysis demonstrated that unlike nodules from control-FTE organoids, BRCA1mut-FTE organoids showed substantial nuclear TP53 accumulation, which is the hallmark of an early time point in ovarian cancer development (Figure S7C).